Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors

Blood measurement of neuroendocrine gene transcripts defines the effectiveness of operative resection and ablation strategies

(2016) Irvin M. Modlin et al.   SURGERY

Blood and tissue neuroendocrine tumor gene cluster analysis correlate, define hallmarks and predict disease status

(2015) Mark Kidd et al.   ENDOCRINE-RELATED CANCER

Specific efficacy of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced neuroendocrine tumours of the small intestine

(2015) Amir Sabet et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Gene transcript analysis blood values correlate with 68Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status

(2015) L. Bodei et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Feasibility and utility of re-treatment with 177Lu-DOTATATE in GEP-NENs relapsed after treatment with 90Y-DOTATOC

(2015) Stefano Severi et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Circulating Transcript Analysis (NETest) in GEP-NETs Treated With Somatostatin Analogs Defines Therapy

(2015) Jarosław B. Ćwikła et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Consensus on biomarkers for neuroendocrine tumour disease

(2015) Kjell Oberg et al.   LANCET ONCOLOGY

Hypoxia induces a lipogenic cancer cell phenotype via HIF1α-dependent and -independent pathways

(2015) Alessandro Valli et al.   Oncotarget

Defective pantothenate metabolism and neurodegeneration

(2014) Susan J. Hayflick   BIOCHEMICAL SOCIETY TRANSACTIONS

Gastrointestinal neuroendocrine tumors (NETs): new diagnostic and therapeutic challenges

(2014) J. P. Castaño et al.   CANCER AND METASTASIS REVIEWS

Unraveling Tumor Grading and Genomic Landscape in Lung Neuroendocrine Tumors

(2014) Giuseppe Pelosi et al.   ENDOCRINE PATHOLOGY

The 2010 WHO Classification of Digestive Neuroendocrine Neoplasms: a Critical Appraisal four years after Its Introduction

(2014) G. Rindi et al.   ENDOCRINE PATHOLOGY

A multianalyte PCR blood test outperforms single analyte ELISAs (chromogranin A, pancreastatin, neurokinin A) for neuroendocrine tumor detection

(2014) Irvin M Modlin et al.   ENDOCRINE-RELATED CANCER

177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II study

(2014) Giovanni Paganelli et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Predictors of Long-Term Outcome in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate

(2014) S. Ezziddin et al.   JOURNAL OF NUCLEAR MEDICINE

SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors

(2014) C. Kratochwil et al.   MOLECULAR IMAGING AND BIOLOGY

Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors

(2013) Su-Chen Li et al.   MODERN PATHOLOGY

Treatment with the Radiolabelled Somatostatin Analog177Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors

(2013) Maddalena Sansovini et al.   NEUROENDOCRINOLOGY

Early prediction of tumour response to PRRT

(2013) S. Ezziddin et al.   NUKLEARMEDIZIN-NUCLEAR MEDICINE

Pattern and Clinical Predictors of Lymph Node Involvement in Nonfunctioning Pancreatic Neuroendocrine Tumors (NF-PanNETs)

(2013) Stefano Partelli et al.   JAMA Surgery

Diagnostic work-up of gastroenteropancreatic neuroendocrine tumors

(2012) K Oberg   Clinics

Circulating Tumor Cells As Prognostic Markers in Neuroendocrine Tumors

(2012) Mohid S. Khan et al.   JOURNAL OF CLINICAL ONCOLOGY

Therapeutic Monitoring of Gastroenteropancreatic Neuroendocrine Tumors: The Challenges Ahead

(2012) Anders Sundin et al.   NEUROENDOCRINOLOGY

THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience

(2012) Richard P. Baum et al.   Theranostics

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Decreased expression of genes involved in oxidative phosphorylation in human pancreatic islets from patients with type 2 diabetes

(2011) Anders H Olsson et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Biomarkers and Molecular Imaging in Gastroenteropancreatic Neuroendocrine Tumors

(2011) D. Lindholm et al.   HORMONE AND METABOLIC RESEARCH

Ornithine Decarboxylase AntizymeOaz3Modulates Protein Phosphatase Activity

(2011) Yibing Ruan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Response and Long-Term Control of Bone Metastases After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate

(2011) S. Ezziddin et al.   JOURNAL OF NUCLEAR MEDICINE

Identification of a Novel Raf-1 Pathway Activator that Inhibits Gastrointestinal Carcinoid Cell Growth

(2010) M. R. Cook et al.   MOLECULAR CANCER THERAPEUTICS

A Nomogram to Assess Small-Intestinal Neuroendocrine Tumor (‘Carcinoid’) Survival

(2010) Irvin M. Modlin et al.   NEUROENDOCRINOLOGY

Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors

(2010) Dik J. Kwekkeboom et al.   SEMINARS IN NUCLEAR MEDICINE

Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors

(2009) Dik J Kwekkeboom et al.   ENDOCRINE-RELATED CANCER

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers

(2009) Dermot O’Toole et al.   NEUROENDOCRINOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors

(2008) Lisa Bodei et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival

(2008) Dik J. Kwekkeboom et al.   JOURNAL OF CLINICAL ONCOLOGY

Gastroenteropancreatic neuroendocrine tumours

(2008) Irvin M Modlin et al.   LANCET ONCOLOGY